| Fund ID | 805-4957153758 |
| Fund type | Other Private Fund — PROCEEDS FROM THE SALE OF THE FUND'S UNITS USED TO PURCHASE AND ACQUIRE EQUITY SECURITIES OF IQHQ, INC. IN A PRIVATE OFFERING. |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 5% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| New Millennium Fundamental Hedged Equity Qp, L.P. | Hedge | $75.6M |
| New Millennium Fundamental Hedged Equity, L.P. | Hedge | $47.9M |
| Telemus Decorrelation Opportunity Fund, LP | Hedge | $3.4M |
Telemus Life Science Real Estate Fund, LLC reports $10.6 million in gross assets, among the top 77% of private funds by size.
The stated minimum investment is $100,000.
Telemus Life Science Real Estate Fund, LLC is managed by Kovitz Investment Group Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.